Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05494_nanopub.RAjdj4OWSL0hfRJpr32hYLRfGbrIt8o04slgdhE0NB-u4#assertion>. }
Showing items 1 to 15 of
15
with 100 items per page.
- drugbank:DB05494 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05494 label "CP-4055 [drugbank:DB05494]" assertion.
- drugbank:DB05494 seeAlso DB05494 assertion.
- drugbank:DB05494 identifier "drugbank:DB05494" assertion.
- drugbank:DB05494 description "CP-4055 is a fatty acid derivative of cytarabine, an approved cytotoxic cancer drug. Cytarabine has limitations such as minimal uptake in solid tumours and is only used to treat leukaemia. CP-4055 is designed to overcome this limitation and has shown considerable uptake in solid tumour cells. CP-4055 is a patented new chemical entity of the nucleoside analog class, with improved biological properties and the potential to treat solid tumours such as non-small cell lung cancer, malignant melanoma and ovarian cancer." assertion.
- drugbank:DB05494 title "CP-4055" assertion.
- drugbank:DB05494 bio2rdf_vocabulary:identifier "DB05494" assertion.
- drugbank:DB05494 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05494 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05494" assertion.
- drugbank:DB05494 bio2rdf_vocabulary:x-identifiers.org DB05494 assertion.
- drugbank:DB05494 drugbank_vocabulary:drugbank-id "DB05494" assertion.
- drugbank:DB05494 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05494 drugbank_vocabulary:x-chemspider chemspider:576 assertion.
- drugbank:DB05494 drugbank_vocabulary:x-pubchemcompound pubchem.compound:596 assertion.
- drugbank:DB05494 drugbank_vocabulary:x-bindingdb bindingdb:50004746 assertion.